• Research into New Therapies for Sickle Cell Disease Gets Funding Boost
  • FDA Awards UNC Researcher $2M Grant to Study Kidney Disease in Sickle Cell Anemia
  • 23-year Study of Cancer Incidence Among SCD Patients is a Mixed Bag
  • Sancilio Completes Clinical Trial Evaluating Altemia in Kids, Teens with Sickle Cell Disease
  • Poll of African-Americans Finds Only a Third Aware of SCD’s Racial Disparities
  • Phase 1 Trial Shows Imara’s Potential Therapy Safe for Treatment of Sickle Cell Disease
  • FDA Gives Rare Pediatric Disease Designation to Sancilio Pharmaceuticals’ Altemia
  • PCORI Awards $18 Million to 2 Projects Helping Patients Transition to Adult Care
  • Bioverativ, Bicycle Therapeutics Partner to Develop Sickle Cell Disease Therapeutics
  • CSL Behring’s Acquisition of Calimmune May Spur New Therapies to Treat Sickle Cell Disease
  • Opioid Abuse Backlash Could Hurt Sickle Cell Patients’ Medication Needs, Some Fear
  • Computer Model Reveals Underlying Mechanism of Hemoglobin S Fibers in Sickle Cell Disease